Prescription drug · NDA AUTHORIZED GENERIC
Metoprolol Succinate NDC 71205-162
Metoprolol succinate 50 mg/1 · Tablet, Extended release · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-162-30 | 71205016230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-162-30)Marketed from Nov 1, 2018 | |
| 71205-162-60 | 71205016260 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-162-60)Marketed from Nov 1, 2018 | |
| 71205-162-90 | 71205016290 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-162-90)Marketed from Nov 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol Succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 50 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 019962
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 71205-162_cc58a663-d683-41fb-bf47-1e07ffaa0fe0SPL ID cc58a663-d683-41fb-bf47-1e07ffaa0fe0SPL set ID e236f1ed-b400-4854-81c7-64964422a2f7RxCUI 866436UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205016230followed by a unit qualifier and the quantityPackage 71205-0162-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Metoprolol Succinate is a beta 1 -selective adrenoceptor blocking agent. Metoprolol Succinate is indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) • Angina Pectoris. (1.2) • Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin. (1.3) 1.1 Hypertension Metoprolol succinate is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily str…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019962
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Toprol XLmetoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-035 |
| Toprol XLmetoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Melinta Therapeutics, LLC | 70842-111 |
| Toprol XLmetoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Melinta Therapeutics, LLC | 70842-110 |
| Toprol XLmetoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Melinta Therapeutics, LLC | 70842-112 |
| Toprol XLmetoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Melinta Therapeutics, LLC | 70842-113 |